The Board of Directors of Reneo Pharmaceuticals, Inc. has authorized a buyback plan on October 30, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | +1.09% | +6.65% | +15.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.31% | 61.16M | |
+24.95% | 46.71B | |
+48.83% | 41.8B | |
-1.23% | 41.52B | |
-3.42% | 29.55B | |
+10.63% | 25.78B | |
-21.06% | 19.26B | |
+0.78% | 12.14B | |
-2.06% | 12.08B | |
+26.84% | 11.98B |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Reneo Pharmaceuticals, Inc. authorizes a Buyback Plan.